Łukasz Filipczyk

Łukasz Filipczyk

Auto-generated profile, based on publicly available information

Łukasz Filipczyk

Department of Histology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2019 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
ASAleksandra Suszka‐Świtek
Aleksandra Suszka‐Świtek
APArtur Pałasz
Artur Pałasz
ŁFŁukasz Filipczyk
Łukasz Filipczyk
IMItiana Castro Menezes-Pazini
Itiana Castro Menezes-Pazini
KMKinga Mordecka‐Chamera
Kinga Mordecka‐Chamera
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz

2 November 2019 in Nutritional Neuroscience
Verified
Journal Article
Closed access
APArtur Pałasz
Artur Pałasz
MTMarta Tyszkiewicz-Nwafor
Marta Tyszkiewicz-Nwafor
ASAleksandra Suszka-Świtek
Aleksandra Suszka-Świtek
Flora BacopoulouFlora Bacopoulou
Flora Bacopoulou
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz
It is hypothesized that novel neuropeptides such as phoenixin (PNX), spexin (SPX), and kisspeptin (KISS) are involved in the pathogenesis of eating disorders. The study presented here analyzed neur...

1 December 2016 in Pharmacological Reports
Verified
Journal Article
Closed access
APArtur Pałasz
Artur Pałasz
ASAleksandra Suszka-Świtek
Aleksandra Suszka-Świtek
ŁFŁukasz Filipczyk
Łukasz Filipczyk
KBKatarzyna Bogus
Katarzyna Bogus
RRRojczyk Rojczyk
Rojczyk Rojczyk
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz

15 February 2019 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
APArtur Pałasz
Artur Pałasz
KBKatarzyna Bogus
Katarzyna Bogus
ASAleksandra Suszka-Świtek
Aleksandra Suszka-Świtek
AKAndrzej Kaśkosz
Andrzej Kaśkosz
SSShirley Saint-Remy
Shirley Saint-Remy
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz
Neuropeptides are involved in various brain activities being able to control a wide spectrum of higher mental functions. The purpose of this concise structural investigation was to detect the possible immunoreactivity of the novel multifunctional neuropeptide nesfatin-1 within the human bed nucleus of the stria terminalis (BNST). The BNST is involved in the mechanism of fear learning, integration of stress and reward circuits, and pathogenesis of addiction. Nesfatin-1-expressing neurons were identified for the first time in several regions of the BNST using both immunohistochemical and fluorescent methods. This may implicate a potential contribution of this neuropeptide to the BNST-related mechanisms of stress/reward responses in the human brain.

27 February 2018 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
APArtur Pałasz
Artur Pałasz
MPMarcelina Pałka
Marcelina Pałka
ŁFŁukasz Filipczyk
Łukasz Filipczyk
IMItiana Castro Menezes-Pazini
Itiana Castro Menezes-Pazini
RRRojczyk Rojczyk
Rojczyk Rojczyk
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz
Neuroleptics modulate the expression level of some regulatory neuropeptides in the brain. However, if these therapeutics influence the peptidergic circuits in the amygdala remains unclear. This study specifies the impact profile of the classical antipsychotic drugs on mRNA expression of the spexin/NPQ, kisspeptin-1 and POMC in the rat amygdala. Animals were treated with haloperidol and chlorpromazine for 28 days prior to transcript quantification via qPCR. Haloperidol and chlorpromazine induced a change in the expression of all neuropeptides analyzed. Both drugs led to the decrease of Kiss-1 expression, whereas in POMC and spexin/NPQ their up-regulation in the amygdala was detected. These modulating effects on may represent alternative, so far unknown mechanisms, of classical antipsychotic drugs triggering pharmacological responses.

15 October 2015 in Acta Neuropsychiatrica
Verified
Journal Article
Closed access
PDF file
APArtur Pałasz
Artur Pałasz
RRRojczyk Rojczyk
Rojczyk Rojczyk
MGMilosz Golyszny
Milosz Golyszny
LFLukasz Filipczyk
Lukasz Filipczyk
JWJohn J. Worthington
John J. Worthington
RWRyszard Wiaderkiewicz
Ryszard Wiaderkiewicz
Objective: The brainstem-derived neuropeptide S (NPS) has a multidirectional regulatory activity, especially as a potent anxiolytic factor. Accumulating data suggests that neuroleptics affect peptidergic signalling in various brain structures. However, there is no information regarding the influence of haloperidol on NPS and NPS receptor (NPSR) expression.Methods: We assessed NPS and NPSR mRNA levels in brains of rats treated with haloperidol using quantitative real-time polymerase chain reaction.Results: Chronic haloperidol treatment (4 weeks) led to a striking upregulation of NPS and NPSR expression in the rat brainstem. Conversely, the NPSR mRNA expression was decreased in the hippocampus and striatum.Conclusions: This stark increase of NPS in response to haloperidol treatment supports the hypothesis that this neuropeptide is involved in the dopamine-dependent anxiolytic actions of neuroleptics and possibly also in the pathophysiology of mental disorders. Furthermore, our findings underline the complex nature of potential interactions between dopamine receptors and brain peptidergic pathways, which has potential clinical applications.